Does early initiation of ART in infants affect virological and resistance outcomes? Data from the CHER trial after 6 years of follow-up

Documenti analoghi

• Reactivity of routine HIV antibody tests in children who initiated antiretroviral therapy in early infancy as part of the Children with HIV Early Antiretroviral Therapy (CHER) trial
  di: Payne, H, et al.
  Pubblicazione: (2015)
• Early limited antiretroviral therapy is superior to deferred therapy in HIV-infected South African infants: results from the CHER (Children with HIV Early antiRetroviral) Randomized Trial
  di: Cotton, Mark F, et al.
  Pubblicazione: (2013)
• Virological findings from the SARA trial: boosted PI monotherapy as maintenance second-line ART in Africa
  di: Pillay, D, et al.
  Pubblicazione: (2010)
• A child with perinatal HIV infection and long-term sustained virological control following antiretroviral treatment cessation
  di: Violari, Avy, et al.
  Pubblicazione: (2019)
• Single Genome Analysis for the Detection of Linked Multiclass Drug Resistance Mutations in HIV-1-Infected Children After Failure of Protease Inhibitor-Based First-Line Therapy
  di: Lange, Camille Marie, et al.
  Pubblicazione: (2015)